ctrl K

AI Score

Unlock

Kiniksa Pharmaceuticals L... (KNSA)

AI Score

Unlock

23.08

-0.28 (-1.20%)

At close: Mar 28, 2025, 3:59 PM

23.09

0.04%

After-hours: Mar 28, 2025, 05:42 PM EDT

Kiniksa Pharmaceuticals Ltd. Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Revenue	423.24M	270.26M	220.18M	38.54M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	56.52M	46.97M	9.1M	3.81M	3.28M	286K	28K	22K
Gross Profit	423.24M	213.74M	173.21M	29.44M	-3.81M	-3.28M	-286K	-28K	-22K
Operating Income	-45.62M	-25.2M	7.37M	-156.64M	-157.36M	-169.96M	-108.16M	-65.4M	-24M
Interest Income	n/a	8.54M	1.25M	97K	1.13M	6.05M	4.72M	529K	65K
Pretax Income	-36.15M	-16.65M	11.03M	-156.54M	-156.23M	-163.91M	-103.44M	-64.87M	-23.94M
Net Income	-43.19M	14.08M	183.36M	-157.92M	-161.38M	-161.87M	-103.23M	-64.87M	-23.97M
Selling & General & Admin	168.01M	129.43M	97.95M	85.95M	45.32M	34.96M	21.56M	9.04M	6.56M
Research & Development	111.62M	76.1M	65.49M	99.3M	112.04M	135M	86.6M	56.36M	17.44M
Other Expenses	189.22M	33.41M	1.25M	835K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	468.86M	238.93M	163.44M	186.08M	157.36M	169.96M	108.16M	65.4M	24M
Interest Expense	n/a	n/a	1.25M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	468.86M	295.45M	210.41M	195.18M	157.36M	169.96M	108.16M	65.4M	24M
Income Tax	7.04M	-30.74M	-172.34M	1.39M	5.15M	-2.05M	-214K	2K	36K
Shares Outstanding (Basic)	71.42M	70.06M	69.38M	68.58M	61.84M	54.05M	29.55M	32.47M	32.47M
Shares Outstanding (Diluted)	71.42M	71.92M	70.42M	68.58M	61.84M	54.05M	29.55M	32.47M	32.47M
EPS (Basic)	-0.6	0.20	2.64	-2.3	-2.61	-2.99	-3.49	-2	-0.74
EPS (Diluted)	-0.6	0.20	2.60	-2.3	-2.61	-2.99	-3.49	-2	-0.74
EBITDA	-45.62M	-22.86M	9.77M	-154.28M	-152.42M	-167.9M	-107.87M	-65.37M	-23.98M
Depreciation & Amortization	n/a	2.34M	4.22M	4.09M	3.81M	3.28M	286K	28K	22K